Dengue Fever Quick Facts | Know about Dengue Symptoms and Dengue Treatment

pharmanewsdaily- March 12, 2018

Quick read about dengue epidemic and how the dengue virus infection is caused by a single mosquito bite. All you need to know about dengue ... Read More

Yoga Health Benefits | Yoga – The Cheapest and Most Effective Health Plan!

pharmanewsdaily- March 11, 2018

Our online Yoga introduction class will give you a list of yoga health benefits and have the yoga types explained for you in this as ... Read More

Colon Cleansing Benefits | Does Colon Cleansing Really Help in Weight Loss?

pharmanewsdaily- March 11, 2018

Find out what is colon cleansing and get information on colon cleansing facts, colon cleansing side effects, colon irrigation and colon cleansing methods here. Though ... Read More

Five Lemon Water Health Benefits You Need to Know

pharmanewsdaily- March 10, 2018

Lemon water health benefits : Begin your day with lemon water in the early morning as it is enriched with antioxidants to give several health ... Read More

FDA approves Luxturna gene therapy for inherited vision loss

pharmanewsdaily- December 30, 2017

In a significant advancement for medical science, Luxturna (voretigene neparvovec), developed by Spark Therapeutics, has been approved by the U.S. Food and Drug Administration (FDA) ... Read More

Mylan launches generic Estradiol Vaginal Cream after securing FDA approval

pharmanewsdaily- December 30, 2017

Mylan, a global pharmaceutical company, has recently announced the U.S. Food and Drug Administration (FDA) approval of its Estradiol Vaginal Cream USP, 0.01%, a generic ... Read More

Eli Lilly’s Cyramza fails to improve survival in gastric cancer trial despite meeting initial goal

pharmanewsdaily- December 11, 2017

In a recent announcement, Eli Lilly and Company disclosed that its phase 3 RAINFALL trial of the drug Cyramza (ramucirumab) for the treatment of HER2-negative ... Read More

FDA approves Amgen’s Repatha for heart attack and stroke prevention

pharmanewsdaily- December 9, 2017

In a significant advancement for cardiovascular disease management, Amgen's Repatha (evolocumab) has received approval from the U.S. Food and Drug Administration (FDA) to prevent heart ... Read More

FDA approves ViiV Healthcare’s Juluca for maintenance treatment of HIV-1

pharmanewsdaily- November 25, 2017

ViiV Healthcare, a joint venture between GlaxoSmithKline (GSK), Pfizer, and Shionogi, has received approval from the U.S. Food and Drug Administration (FDA) for its two-drug ... Read More

FDA grants accelerated approval to AstraZeneca’s Calquence for mantle cell lymphoma treatment

pharmanewsdaily- November 1, 2017

AstraZeneca has achieved a significant milestone with the early FDA approval of Calquence (acalabrutinib) for the treatment of adult patients with mantle cell lymphoma who ... Read More